CA Stock MarketDetailed Quotes

QNTM Quantum BioPharma Ltd

Watchlist
  • 7.300
  • +0.100+1.39%
15min DelayMarket Closed Nov 15 14:39 ET
13.56MMarket Cap-410P/E (TTM)

Quantum BioPharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
82.72%-606.48K
58.49%-1.97M
60.18%-10.83M
86.54%-851.65K
77.21%-1.71M
59.94%-3.51M
-3.59%-4.75M
-40.42%-27.19M
-60.76%-6.33M
-75.91%-7.52M
Net income from continuing operations
38.94%-3.35M
79.00%-2.09M
31.73%-18.23M
73.14%-1.65M
84.13%-1.13M
31.07%-5.49M
-82.34%-9.96M
21.32%-26.7M
0.24%-6.15M
-26.97%-7.13M
Operating gains losses
150.18%164.68K
133.89%484.04K
-244.50%-595.77K
-165.72%-482.56K
-98.89%8.03K
-205.21%-328.19K
146.76%206.95K
160.41%412.29K
72.63%-181.6K
358.10%724.53K
Depreciation and amortization
-87.65%136.81K
-89.37%120.14K
-44.73%2.51M
-89.41%122.22K
-87.19%146.81K
-2.28%1.11M
2.61%1.13M
12.09%4.53M
4.23%1.15M
14.06%1.15M
Asset impairment expenditure
--0
--0
--4.56M
--236.19K
--0
--3.84M
--480.1K
--0
--0
--0
Unrealized gains and losses of investment securities
--0
--0
61.56%378.43K
253.96%103.26K
-48.70%-2.17K
-45.25%100.05K
47.70%177.28K
-72.72%234.23K
-109.89%-67.07K
-100.19%-1.46K
Remuneration paid in stock
-72.35%111.52K
-98.20%57.74K
150.48%3.84M
-80.38%99.38K
-78.49%126.16K
13.63%403.39K
3,755.82%3.21M
-79.43%1.53M
48.31%506.58K
135.36%586.51K
Other non cashItems
100.29%8.36K
423.14%12.41K
-6,147.98%-4.91M
118.26%3.09K
-11,099.61%-2.01M
-15,227.04%-2.91M
103.76%2.37K
-501.09%-78.66K
-157.90%-16.91K
-1,011.04%-17.91K
Change In working capital
1,126.30%2.32M
-245,168.28%-556.31K
123.00%1.64M
145.67%718.33K
140.56%1.15M
91.90%-226.51K
-99.69%227
-346.49%-7.12M
-314.01%-1.57M
-617.31%-2.82M
-Change in receivables
232.14%1.15M
349.13%610.74K
89.90%-728.72K
-4.61%-1.52M
163.52%1.91M
66.25%-870.54K
-43.69%-245.15K
-6,651.95%-7.22M
-1,539.51%-1.46M
-2,348.75%-3.01M
-Change in prepaid assets
-57.39%142.67K
67.79%-117.68K
-60.21%316.72K
-66.98%192.95K
-59.85%154.32K
1,404.71%334.86K
-87.37%-365.4K
230.66%795.93K
1,475.19%584.31K
-13.36%384.39K
-Change in payables and accrued expense
233.69%1.03M
-271.81%-1.05M
392.92%2.05M
----
----
229.63%309.17K
39.24%610.78K
-119.41%-699.78K
----
----
Cash from discontinued investing activities
0
0
17.30%-1.14M
0
0
Operating cash flow
82.72%-606.48K
58.49%-1.97M
61.79%-10.83M
86.54%-851.65K
77.21%-1.71M
62.66%-3.51M
6.66%-4.75M
-36.57%-28.33M
-54.64%-6.33M
-63.85%-7.52M
Investing cash flow
Cash flow from continuing investing activities
738.22K
-22.14K
55.63%-269.58K
0
-178.15%-269.58K
0
0
-325.88%-607.53K
-919.64%-392.53K
-113.44%-96.92K
Net PPE purchase and sale
----
----
--0
--0
----
----
----
---113.96K
--2.92K
---96.92K
Net intangibles purchas and sale
----
----
--0
--0
----
----
----
50.00%-250K
--0
--0
Net business purchase and sale
----
----
--31.78K
--0
----
----
----
--0
--0
----
Net investment purchase and sale
--738.22K
---22.14K
-23.72%-301.36K
--0
---301.36K
--0
--0
---243.58K
---395.45K
--0
Cash from discontinued investing activities
0
0
12.73M
0
0
Investing cash flow
--738.22K
---22.14K
-102.22%-269.58K
--0
-178.15%-269.58K
--0
--0
4,407.45%12.12M
-919.64%-392.53K
-113.44%-96.92K
Financing cash flow
Cash flow from continuing financing activities
4,378.90%1.84M
118.94%568.72K
-51.09%-3.13M
49.10%-25.22K
78.75%-54.78K
84.34%-43.11K
-102.02%-3M
-105.42%-2.07M
-283.67%-49.54K
-1,582.25%-257.77K
Net issuance payments of debt
102.39%1.31K
601.31%272.28K
-32.14%-189.05K
49.03%-25.25K
-35.38%-54.78K
-32.70%-54.71K
-358.81%-54.31K
-10.63%-143.07K
-283.67%-49.54K
-164.05%-40.46K
Net common stock issuance
--1.84M
110.02%296.44K
-53.55%-2.96M
--34
--0
--0
-100.54%-2.96M
-105.02%-1.93M
--0
---217.31K
Proceeds from stock option exercised by employees
--0
--0
--20.25K
--0
--0
--11.6K
--8.65K
--0
--0
--0
Cash from discontinued financing activities
0
Financing cash flow
4,378.90%1.84M
118.94%568.72K
-51.09%-3.13M
49.10%-25.22K
78.75%-54.78K
84.34%-43.11K
-102.02%-3M
-105.42%-2.07M
-283.67%-49.54K
-1,582.25%-257.77K
Net cash flow
Beginning cash position
-85.58%1.33M
-83.76%2.76M
-51.84%16.98M
-84.70%3.63M
-82.07%5.67M
-67.72%9.22M
-51.84%16.98M
101.20%35.26M
-39.59%23.75M
-26.80%31.62M
Current changes in cash
155.64%1.98M
81.61%-1.43M
22.19%-14.22M
87.04%-876.87K
74.12%-2.04M
-216.61%-3.55M
-16.01%-7.76M
-203.07%-18.28M
-66.88%-6.77M
-102.78%-7.87M
End cash Position
-41.69%3.31M
-85.58%1.33M
-83.76%2.76M
-83.76%2.76M
-84.70%3.63M
-82.07%5.67M
-67.72%9.22M
-51.84%16.98M
-51.84%16.98M
-39.59%23.75M
Free cash from
82.72%-606.48K
58.49%-1.97M
62.27%-10.83M
86.53%-851.65K
77.50%-1.71M
62.68%-3.51M
11.27%-4.75M
-35.07%-28.7M
-56.40%-6.32M
-64.25%-7.61M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 82.72%-606.48K58.49%-1.97M60.18%-10.83M86.54%-851.65K77.21%-1.71M59.94%-3.51M-3.59%-4.75M-40.42%-27.19M-60.76%-6.33M-75.91%-7.52M
Net income from continuing operations 38.94%-3.35M79.00%-2.09M31.73%-18.23M73.14%-1.65M84.13%-1.13M31.07%-5.49M-82.34%-9.96M21.32%-26.7M0.24%-6.15M-26.97%-7.13M
Operating gains losses 150.18%164.68K133.89%484.04K-244.50%-595.77K-165.72%-482.56K-98.89%8.03K-205.21%-328.19K146.76%206.95K160.41%412.29K72.63%-181.6K358.10%724.53K
Depreciation and amortization -87.65%136.81K-89.37%120.14K-44.73%2.51M-89.41%122.22K-87.19%146.81K-2.28%1.11M2.61%1.13M12.09%4.53M4.23%1.15M14.06%1.15M
Asset impairment expenditure --0--0--4.56M--236.19K--0--3.84M--480.1K--0--0--0
Unrealized gains and losses of investment securities --0--061.56%378.43K253.96%103.26K-48.70%-2.17K-45.25%100.05K47.70%177.28K-72.72%234.23K-109.89%-67.07K-100.19%-1.46K
Remuneration paid in stock -72.35%111.52K-98.20%57.74K150.48%3.84M-80.38%99.38K-78.49%126.16K13.63%403.39K3,755.82%3.21M-79.43%1.53M48.31%506.58K135.36%586.51K
Other non cashItems 100.29%8.36K423.14%12.41K-6,147.98%-4.91M118.26%3.09K-11,099.61%-2.01M-15,227.04%-2.91M103.76%2.37K-501.09%-78.66K-157.90%-16.91K-1,011.04%-17.91K
Change In working capital 1,126.30%2.32M-245,168.28%-556.31K123.00%1.64M145.67%718.33K140.56%1.15M91.90%-226.51K-99.69%227-346.49%-7.12M-314.01%-1.57M-617.31%-2.82M
-Change in receivables 232.14%1.15M349.13%610.74K89.90%-728.72K-4.61%-1.52M163.52%1.91M66.25%-870.54K-43.69%-245.15K-6,651.95%-7.22M-1,539.51%-1.46M-2,348.75%-3.01M
-Change in prepaid assets -57.39%142.67K67.79%-117.68K-60.21%316.72K-66.98%192.95K-59.85%154.32K1,404.71%334.86K-87.37%-365.4K230.66%795.93K1,475.19%584.31K-13.36%384.39K
-Change in payables and accrued expense 233.69%1.03M-271.81%-1.05M392.92%2.05M--------229.63%309.17K39.24%610.78K-119.41%-699.78K--------
Cash from discontinued investing activities 0017.30%-1.14M00
Operating cash flow 82.72%-606.48K58.49%-1.97M61.79%-10.83M86.54%-851.65K77.21%-1.71M62.66%-3.51M6.66%-4.75M-36.57%-28.33M-54.64%-6.33M-63.85%-7.52M
Investing cash flow
Cash flow from continuing investing activities 738.22K-22.14K55.63%-269.58K0-178.15%-269.58K00-325.88%-607.53K-919.64%-392.53K-113.44%-96.92K
Net PPE purchase and sale ----------0--0---------------113.96K--2.92K---96.92K
Net intangibles purchas and sale ----------0--0------------50.00%-250K--0--0
Net business purchase and sale ----------31.78K--0--------------0--0----
Net investment purchase and sale --738.22K---22.14K-23.72%-301.36K--0---301.36K--0--0---243.58K---395.45K--0
Cash from discontinued investing activities 0012.73M00
Investing cash flow --738.22K---22.14K-102.22%-269.58K--0-178.15%-269.58K--0--04,407.45%12.12M-919.64%-392.53K-113.44%-96.92K
Financing cash flow
Cash flow from continuing financing activities 4,378.90%1.84M118.94%568.72K-51.09%-3.13M49.10%-25.22K78.75%-54.78K84.34%-43.11K-102.02%-3M-105.42%-2.07M-283.67%-49.54K-1,582.25%-257.77K
Net issuance payments of debt 102.39%1.31K601.31%272.28K-32.14%-189.05K49.03%-25.25K-35.38%-54.78K-32.70%-54.71K-358.81%-54.31K-10.63%-143.07K-283.67%-49.54K-164.05%-40.46K
Net common stock issuance --1.84M110.02%296.44K-53.55%-2.96M--34--0--0-100.54%-2.96M-105.02%-1.93M--0---217.31K
Proceeds from stock option exercised by employees --0--0--20.25K--0--0--11.6K--8.65K--0--0--0
Cash from discontinued financing activities 0
Financing cash flow 4,378.90%1.84M118.94%568.72K-51.09%-3.13M49.10%-25.22K78.75%-54.78K84.34%-43.11K-102.02%-3M-105.42%-2.07M-283.67%-49.54K-1,582.25%-257.77K
Net cash flow
Beginning cash position -85.58%1.33M-83.76%2.76M-51.84%16.98M-84.70%3.63M-82.07%5.67M-67.72%9.22M-51.84%16.98M101.20%35.26M-39.59%23.75M-26.80%31.62M
Current changes in cash 155.64%1.98M81.61%-1.43M22.19%-14.22M87.04%-876.87K74.12%-2.04M-216.61%-3.55M-16.01%-7.76M-203.07%-18.28M-66.88%-6.77M-102.78%-7.87M
End cash Position -41.69%3.31M-85.58%1.33M-83.76%2.76M-83.76%2.76M-84.70%3.63M-82.07%5.67M-67.72%9.22M-51.84%16.98M-51.84%16.98M-39.59%23.75M
Free cash from 82.72%-606.48K58.49%-1.97M62.27%-10.83M86.53%-851.65K77.50%-1.71M62.68%-3.51M11.27%-4.75M-35.07%-28.7M-56.40%-6.32M-64.25%-7.61M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data